OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,191 | -39.1% | 4,201 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $21,677 | -2.1% | 4,201 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $22,139 | +68.9% | 4,201 | -10.0% | 0.00% | 0.0% |
Q4 2022 | $13,111 | -32.3% | 4,666 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $19,364 | +98.8% | 4,666 | +92.6% | 0.00% | – |
Q2 2022 | $9,740 | -61.0% | 2,423 | -52.0% | 0.00% | -100.0% |
Q1 2022 | $24,988 | -80.8% | 5,048 | -73.0% | 0.00% | -50.0% |
Q4 2021 | $130,367 | -34.8% | 18,704 | -6.5% | 0.00% | -33.3% |
Q3 2021 | $200,040 | -29.5% | 20,004 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $283,657 | -3.8% | 20,004 | +11.3% | 0.00% | 0.0% |
Q1 2021 | $295,003 | -24.2% | 17,977 | -4.4% | 0.00% | -33.3% |
Q4 2020 | $389,181 | +172.0% | 18,801 | 0.0% | 0.01% | +100.0% |
Q3 2020 | $143,076 | +12.6% | 18,801 | +23.3% | 0.00% | +50.0% |
Q2 2020 | $127,033 | +72.9% | 15,250 | +2.7% | 0.00% | 0.0% |
Q1 2020 | $73,468 | -99.9% | 14,842 | +21.1% | 0.00% | +100.0% |
Q2 2018 | $82,749,000 | +51943.4% | 12,259 | -28.5% | 0.00% | 0.0% |
Q2 2017 | $159,000 | +14.4% | 17,157 | +73.5% | 0.00% | 0.0% |
Q3 2015 | $139,000 | -33.2% | 9,887 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $208,000 | – | 9,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |